Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Oxalobacter formigenes strain HC-1

EU orphan designation number: EU/3/06/354   
Active ingredient: Oxalobacter formigenes strain HC-1
Indication: Treatment of primary hyperoxaluria
Sponsor: OxThera AB
Sturegatan 56, SE-114 36, Stockholm, Sverige

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
21/02/2006 Centralised Orphan - Designation EMEA/OD/095/05 (2006)558 of 17/02/2006
17/08/2011 Other procedure EMEA/OD/095/05
04/02/2013 Other procedure